Combating the Increasing
Threat of Multi-drug Resistant
Bacterial Infections

As a multi-asset, clinical-stage biopharmaceutical
company, Spero Therapeutics is focused on identifying,
developing and commercializing transformative anti-infective medicines
for multi-drug resistant (MDR) bacterial infections and rare disease.

Leading Product Candidates

Spero Therapeutics is developing a portfolio of novel product candidates with the potential for meaningful patient impact and significant commercial applications. As a leader in the infectious disease field, we are highly committed to advancing new therapies for patients with serious infections.  Our candidates are designed to treat MDR bacterial infections in both the hospital and community settings.  

Talented Team of People with a Mission to Save Lives

Spero has been named one of the 2020 Best Places to Work by the Boston Business Journal.  

Come join our Team!

  • Investors

    Learn about the investment opportunity, see our upcoming events and download our latest corporate presentation.

    Investment opportunities >
  • Careers

    Join a passionate team that pushes the limits in finding innovative therapies to help patients.

    Career opportunities >
  • Partners

    Our strategic partnerships foster mutually beneficial alliances that advance medicine to improve patient lives.

    Partnership opportunities >